12,987
Participants
Start Date
August 23, 2021
Primary Completion Date
December 13, 2021
Study Completion Date
December 13, 2021
No treatment given
No treatment given
Novo Nordisk Investigational Site, Taipei
Novo Nordisk Investigational Site, Mexico City
Novo Nordisk Investigational Site, Riyadh
Novo Nordisk Investigational Site, Madrid
Novo Nordisk Investigational Site, Istanbul
Novo Nordisk Investigational Site, Bogotá
Novo Nordisk Investigational Site, Sydney
Novo Nordisk Investigational Site, Rome
Novo Nordisk Investigational Site, Seoul
Novo Nordisk Investigational Site, Gatwick
Lead Sponsor
Novo Nordisk A/S
INDUSTRY